These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28939142)

  • 1. Correspondence regarding Suba et al., human papillomavirus screening for low and middle-income countries.
    Castle PE
    Prev Med; 2017 Dec; 105():356. PubMed ID: 28939142
    [No Abstract]   [Full Text] [Related]  

  • 2. Correspondence regarding Castle., Human papillomavirus screening for low and middle-income countries.
    Suba EJ
    Prev Med; 2017 Dec; 105():357-358. PubMed ID: 28780060
    [No Abstract]   [Full Text] [Related]  

  • 3. In response to: Human papillomavirus screening for low and middle-income countries.
    Schiffman M
    Prev Med; 2017 Jul; 100():297-298. PubMed ID: 28583663
    [No Abstract]   [Full Text] [Related]  

  • 4. Human papillomavirus DNA and Pap tests: the need for cotesting in opportunistic setting during the transition time.
    Mariani L; Sideri M; Costa S; Cristoforoni P; Origoni M; Preti M;
    J Low Genit Tract Dis; 2013 Jul; 17(3):362-5. PubMed ID: 23552207
    [No Abstract]   [Full Text] [Related]  

  • 5. Cervical cancer prevention: new guidelines in the United States and new opportunities for low- and middle-income countries.
    Waxman AG
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):251-5. PubMed ID: 23732029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus testing for primary cervical cancer screening: is it time to abandon Papanicolaou testing?
    Feldman S
    JAMA Intern Med; 2014 Oct; 174(10):1539-40. PubMed ID: 25069413
    [No Abstract]   [Full Text] [Related]  

  • 7. Human papillomavirus screening for low and middle-income countries.
    Suba EJ; Zarka MA; Raab SS
    Prev Med; 2017 Jul; 100():296. PubMed ID: 28583662
    [No Abstract]   [Full Text] [Related]  

  • 8. Whatever happened to the annual pap smear?
    Vigliani MB
    R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
    [No Abstract]   [Full Text] [Related]  

  • 9. HPV vaccination: effects on cervical screening.
    Kothari A
    Nurs Times; 2014 Jun 11-17; 110(24):19-21. PubMed ID: 25007499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening.
    Wong EL; Chan PK; Chor JS; Cheung AW; Huang F; Wong SY
    Cancer Nurs; 2016; 39(1):E1-E11. PubMed ID: 25730587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer: what is the optimal age for routine testing?
    Rob L; Tachezy R; Robova H
    Future Oncol; 2015; 11(8):1137-40. PubMed ID: 25832869
    [No Abstract]   [Full Text] [Related]  

  • 12. HPV vaccines: bring me your daughters!
    Thomas C
    S Afr Med J; 2008 Apr; 98(4):259-61. PubMed ID: 18637629
    [No Abstract]   [Full Text] [Related]  

  • 13. HPV prevention: waiting for screening services.
    Finn A
    Lancet; 2010 May; 375(9727):1694. PubMed ID: 20472170
    [No Abstract]   [Full Text] [Related]  

  • 14. 2013 statement on human papillomavirus DNA test utilization.
    Davey DD; Goulart R; Nayar R;
    Am J Clin Pathol; 2014 Apr; 141(4):459-61. PubMed ID: 24619744
    [No Abstract]   [Full Text] [Related]  

  • 15. Human papillomavirus vaccine introduction in Vietnam: formative research findings.
    Nghi NQ; Lamontagne DS; Bingham A; Rafiq M; Mai le TP; Lien NT; Khanh NC; Hong DT; Huyen DT; Tho NT; Hien NT
    Sex Health; 2010 Sep; 7(3):262-70. PubMed ID: 20719213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus, current vaccines, and cervical cancer prevention.
    Teitelman AM; Stringer M; Averbuch T; Witkoski A
    J Obstet Gynecol Neonatal Nurs; 2009; 38(1):69-80. PubMed ID: 19208050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries.
    Luciani S; Jauregui B; Kieny C; Andrus JK
    Immunotherapy; 2009 Sep; 1(5):795-807. PubMed ID: 20636024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].
    Phan DP; Pham QT; Strobel M; Tran DS; Tran TL; Buisson Y
    Rev Epidemiol Sante Publique; 2012 Dec; 60(6):437-46. PubMed ID: 23137871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
    Almonte M; Sasieni P; Cuzick J
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
    Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
    Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.